Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion type Assertion NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_head.
- NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion description "[Within 17q, the genes topoisomerase II-alpha (TOP2A), ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4) and baculoviral IAP repeat-containing 5 (survivin) (BIRC5) showed increased expression in all samples compared to two benign tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_provenance.
- NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion evidence source_evidence_literature NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_provenance.
- NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion SIO_000772 18522746 NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_provenance.
- NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion wasDerivedFrom befree-2016 NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_provenance.
- NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_assertion wasGeneratedBy ECO_0000203 NP674828.RA0XYeWfMLyNiJVt2q8d9sUI58-rLYTPD5YgHzYuujAM4130_provenance.